HomeCompareAGRPY vs MRK

AGRPY vs MRK: Dividend Comparison 2026

AGRPY yields 7.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGRPY wins by $56451.25M in total portfolio value
10 years
AGRPY
AGRPY
● Live price
7.27%
Share price
$27.37
Annual div
$1.99
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56451.31M
Annual income
$54,998,166,854.86
Full AGRPY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AGRPY vs MRK

📍 AGRPY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGRPYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGRPY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AGRPY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGRPY
Annual income on $10K today (after 15% tax)
$618.01/yr
After 10yr DRIP, annual income (after tax)
$46,748,441,826.63/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AGRPY beats the other by $46,748,433,498.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGRPY + MRK for your $10,000?

AGRPY: 50%MRK: 50%
100% MRK50/50100% AGRPY
Portfolio after 10yr
$28225.68M
Annual income
$27,499,088,326.50/yr
Blended yield
97.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AGRPY
No analyst data
Altman Z
0.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGRPY buys
0
MRK buys
0
No recent congressional trades found for AGRPY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGRPYMRK
Forward yield7.27%2.76%
Annual dividend / share$1.99$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$56451.31M$56.8K
Annual income after 10y$54,998,166,854.86$9,798.13
Total dividends collected$56351.66M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AGRPY vs MRK ($10,000, DRIP)

YearAGRPY PortfolioAGRPY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,154$1,454.15$11,206$366.19+$948.00AGRPY
2$16,308$3,303.54$12,650$502.35+$3.7KAGRPY
3$25,735$8,285.41$14,407$694.19+$11.3KAGRPY
4$51,976$24,438.76$16,585$967.82+$35.4KAGRPY
5$147,870$92,255.79$19,342$1,363.89+$128.5KAGRPY
6$648,811$490,590.20$22,913$1,947.19+$625.9KAGRPY
7$4,717,725$4,023,497.33$27,662$2,823.89+$4.69MAGRPY
8$59,732,488$54,684,522.14$34,159$4,173.35+$59.70MAGRPY
9$1,358,075,698$1,294,161,935.83$43,337$6,308.80+$1358.03MAGRPY
10$56,451,307,852$54,998,166,854.86$56,776$9,798.13+$56451.25MAGRPY

AGRPY vs MRK: Complete Analysis 2026

AGRPYStock

Absa Group Limited, together with its subsidiaries, provides various financial products and services in South Africa and internationally. The company operates through Retail and Business Banking; Corporate and Investment Banking; and Head Office, Treasury and Other Operations. It provides retail, business, corporate, investment banking, insurance, financial, and wealth management products and services. The company offers retail and business banking products and services to individual, enterprise, and commercial customers, including residential property-related finance solutions; vehicle and asset finance products and services; credit cards; personal loans; relationship banking; short-term insurance products; transactional banking, savings, and investment products and services; and rewards program and services. It also provides commercial property finance and term loans. In addition, the company offers investment banking services; private equity and infrastructure investments; corporate banking products and services; and wealth management services. Further, it provides life insurance products covering death, disability and retrenchment, funeral, and life wrapped investment products; investments, such as asset management, multi-management, unit trusts, and investment products; treasury services; and wealth and financial advisory services. Additionally, the company offers market services; trade and working capital solutions; and cash management, payment, and liquidity products and solutions. It also offers broker-dealer trading in debt and equity securities; and solicitation, syndication, selling, and arranging of equity and debt products, as well as financial, leasing, and management services. The company was formerly known as Barclays Africa Group Limited and changed its name to Absa Group Limited in May 2018. Absa Group Limited was incorporated in 1986 and is based in Johannesburg, South Africa.

Full AGRPY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AGRPY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGRPY vs SCHDAGRPY vs JEPIAGRPY vs OAGRPY vs KOAGRPY vs MAINAGRPY vs JNJAGRPY vs ABBVAGRPY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.